Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults
This study has been completed.
Sponsors and Collaborators: Beth Israel Deaconess Medical Center
Mind/Body Medical Institute
Information provided by: Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT00179530
  Purpose

To evaluate whether a 5-week relaxation response intervention influences the learning, memory or attention of healthy older adults.


Condition Intervention Phase
Healthy
 Behavioral: Relaxation Response
 Phase II

MedlinePlus related topics: Memory
Drug Information available for: Hydrocortisone Cortisol 21-phosphate Cortisol succinate Hydrocortamate Hydrocortisone 21-sodium succinate Hydrocortisone acetate Hydrocortisone cypionate Hydrocortisone hemisuccinate Proctofoam-HC
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Placebo Control, Parallel Assignment, Efficacy Study
Official Title: The Effect of Relaxation Response Training on Declarative Memory and Salivary Cortisol in Older Adults

Further study details as provided by Beth Israel Deaconess Medical Center:

Primary Outcome Measures:
  • Evaluate whether a RR training program would decrease anxiety levels, improve attention, declarative memory performance in healthy older adults. [ Time Frame: 8 weeks ]

Secondary Outcome Measures:
  • Evaluate whether a RR training program would decrease salivary cortisol levels in healthy older adults. [ Time Frame: 8 weeks ]

Enrollment: 16
Study Start Date: May 1999
Study Completion Date: September 2007
Intervention Details:
    Behavioral: Relaxation Response
    Relaxation training
  Eligibility

Ages Eligible for Study:   65 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 65 to 80 years od age
  • No prior or current psychiatric or neurological condition.
  • score above 24 on the Mini-Mental State Exam (MMSE)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00179530

Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Mind/Body Medical Institute
Investigators
Principal Investigator: Jeffery A Dusek, PhD Beth Israel Deaconess Medical Center, Mind/Body Medical Institute
  More Information

Study ID Numbers: 2001-P-002249
Study First Received: September 13, 2005
Last Updated: November 2, 2007
ClinicalTrials.gov Identifier: NCT00179530  
Health Authority: United States: Food and Drug Administration

Study placed in the following topic categories:
Hydrocortisone
Cortisol succinate
Hydrocortisone acetate
Healthy

ClinicalTrials.gov processed this record on January 14, 2009



U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services